The quality of guidelines in non-pharmacological prevention and management of chemotherapy-induced neuropathy: A review

  • Shahin Salarvand Social Determinant Health Research Center, Faculty of Nursing and Midwifery, Lorestan University of Medical Sciences, Khorramabad, Iran, Islamic Republic of.
  • Simin Hemati Radiation oncology department, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran, Islamic Republic of.
  • Payman Adibi Integrative Functional Gastroenterology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran, Islamic Republic of.
  • Fariba Taleghani | taleghani@nm.mui.ac.ir Nursing and Midwifery Care Research Center, Faculty of Nursing and Midwifery, Isfahan University of Medical Sciences, Isfahan, Iran, Islamic Republic of.

Abstract

Chemotherapy-induced peripheral neuropathy is a common adverse effect occurring in patients undergoing neurotoxic chemotherapy. However, there is no FDA-approved treatment option for it. Given the importance of clinical practice guidelines in this area, this study aimed to determine the methodological quality of extant CIPN guidelines. The study was done as part of the adaptation process of CIPN related CPGs at Isfahan University of Medical Sciences, Iran. A systematic search of published CPGs about chemotherapy-induced CIPN in which the AGREE II instrument was applied for appraising CPGs of CIPN was performed. In general, amongst all of the AGREE II Instrument’s domains in the evaluated CPGs, the clarity of presentation and stakeholder involvement domains took favorable scores; and other domains obtained unfavorable and relatively favorable scores. The quality of cancer therapy-induced neuropathy CPGs needs to be improved and designing high-quality CPGs must be considered.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

References

References:

Argyriou AA, Bruna J, Marmiroli P, Cavaletti G. Chemotherapy-induced peripheral neurotoxicity (CIPN): an update. Critical reviews in oncology/hematology. 2012;82(1):51-77.

Fallon M. Neuropathic pain in cancer. British journal of anaesthesia. 2013;111(1):105-11.

Kaley TJ, DeAngelis LM. Therapy of chemotherapy‐induced peripheral neuropathy. British journal of haematology. 2009;145(1):3-14.

NICE CfCPa. Neuropathic pain: the pharmacological management of neuropathic pain in adults in non-specialist settings. 2010.

Brami C, Bao T, Deng G. Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review. Critical reviews in oncology/hematology. 2016;98:325-34.

Brouwers M, Kho ME, Browman GP, Cluzeau F, feder G, Fervers B, et al. on behalf of the AGREE Next Steps Consortium. AGREE II: Advancing guideline development, reporting and evaluation in healthcare. Can Med Assoc J. 2010b;182:E839-E42. UPDATE: September 2013

Burgers JS, Grol R, Klazinga NS, Mäkelä M, Zaat J. Towards evidence-based clinical practice: an international survey of 18 clinical guideline programs. International Journal for Quality in Health Care. 2003a;15(1):31-045.

NICE. The guideline development process: an overview for stakeholders, the public and the NH: Third edition. www.nice.org.uk.P:1-28.; 2007.

Nezamzadeh M, Khademolhosseini SM, Mokhtari Nori J, Ebadi A. Design of guidelines evidence-based nursing care in patients with angina pectoris. Journal of Critical Care Nursing. 2012;4(4):169-76.

Grol R, Cluzeau FA, Burgers JS. Clinical practice guidelines: towards better quality guidelines and increased international collaboration. British Journal Of Cancer. 2003a;89:S4.

Deng W, Li L, Wang Z, Chang X, Li R, Fang Z, et al. Using AGREE II to evaluate the quality of traditional medicine clinical practice guidelines in China. Journal of Evidence‐Based Medicine. 2016;9(3):152-62.

Harrison MB, Légaré F, Graham ID, Fervers B. Adapting clinical practice guidelines to local context and assessing barriers to their use. Canadian Medical Association Journal. 2010;182(2):E78-E84.

Adapte Collaboration. The ADAPTE process: resource toolkit for guideline adaptation. Guidelines International Network [Internett]. 2009.

Font‐Gonzalez A, Mulder RL, Loeffen EA, Byrne J, van Dulmen‐den Broeder E, van den Heuvel‐Eibrink MM, et al. Fertility preservation in children, adolescents, and young adults with cancer: Quality of clinical practice guidelines and variations in recommendations. Cancer. 2016; 122(14):2216-23.

Salarvand S, Hemati S, Adibi P, Taleghani F. A Review of the Quality of Extant Clinical Practice Guidelines in Cancer Therapy-Induced Mucositis. International Journal of Cancer Management. 2017(In Press).

Birken SA, Ellis SD, Walker JS, DiMartino LD, Check DK, Gerstel AA, et al. Guidelines for the use of survivorship care plans: a systematic quality appraisal using the AGREE II instrument. Implementation Science. 2015; 10(1):63.

Potting C, Mistiaen P, Poot E, Blijlevens N, Donnelly P, Van Achterberg T. A review of quality assessment of the methodology used in guidelines and systematic reviews on oral mucositis. Journal of clinical nursing. 2009; 18(1):3-12.

Grilli R, Magrini N, Penna A, Mura G, Liberati A. Practice guidelines developed by specialty societies: the need for a critical appraisal. The Lancet. 2000; 355(9198):103-6.

NCCMT NCCfMaT. Critically appraising practice guidelines: The AGREE II instrument. Hamilton, ON: McMaster University: Retrieved from

http://www.nccmt.ca/resources/search/100, 2013.

Dans AL, Dans LF. Appraising a tool for guideline appraisal (the AGREE II instrument). Journal of clinical epidemiology. 2010;63(12):1281-2.

Grol R, Cluzeau F, Burgers J. Clinical practice guidelines: towards better quality guidelines and increased international collaboration. Nature Publishing Group; 2003.

Fervers B, Burgers JS, Haugh MC, Brouwers M, Browman G, Cluzeau F, et al. Predictors of high quality clinical practice guidelines: examples in oncology. International Journal for Quality in Health Care. 2005; 17(2):123-32.

Deng Y, Luo L, Hu Y, Fang K, Liu J. Clinical practice guidelines for the management of neuropathic pain: a systematic review. BMC anesthesiology. 2015; 16(1):12.

Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. Journal of Clinical Epidemiology. 2010d; 63:1308-11.

Burls A. AGREE II—improving the quality of clinical care. The Lancet. 2010; 376(9747):1128-9.

Armstrong JJ, Rodrigues IB, Wasiuta T, MacDermid JC. Quality assessment of osteoporosis clinical practice guidelines for physical activity and safe movement: an AGREE II appraisal. Archives of osteoporosis. 2016; 11(1):1-10.

Bazzano AN, Green E, Madison A, Barton A, Gillispie V, Bazzano LA. Assessment of the quality and content of national and international guidelines on hypertensive disorders of pregnancy using the AGREE II instrument. BMJ open. 2016; 6(1):e009189.

Huang T-W, Lai J-H, Wu M-Y, Chen S-L, Wu C-H, Tam K-W. Systematic review of clinical practice guidelines in the diagnosis and management of thyroid nodules and cancer. BMC medicine. 2013; 11(1):191.

Li CC, Wang YQ, Li YP, Li XL. Critical appraisal of clinical practice guidelines for treating pancreatic cancer based on the global disease burden. Journal of evidence-based medicine. 2015; 8(1):11-21.

Sabharwal S, Patel NK, Gauher S, Holloway I, Athansiou T. High methodologic quality but poor applicability: assessment of the AAOS guidelines using the AGREE II instrument. Clinical Orthopaedics and Related Research®. 2014; 472(6):1982-8.

Brouwers MC, Kho ME, Browman JS, Burgers FC, Gene F, Béatrice F, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. Canadian Medical Association Journal. 2010f; 182(18).

Xie Z, Wang X, Sun L, Liu J, Guo Y, Xu B, et al. Appraisal of clinical practice guidelines on community-acquired pneumonia in children with AGREE II instrument. BMC pediatrics. 2016; 16(1):119.

Burgers J, Fervers B, Haugh M, Brouwers M, Browman G, Philip T, et al. International assessment of the quality of clinical practice guidelines in oncology using the Appraisal of Guidelines and Research and Evaluation Instrument. Journal of Clinical Oncology. 2004;22(10):2000-7.

Cranney A, Waldegger L, Graham I, Man-Son-Hing M, Byszewski A, Ooi D. Systematic assessment of the quality of osteoporosis guidelines. BMC musculoskeletal disorders. 2002; 3(1):20.

Reames BN, Krell RW, Ponto SN, Wong SL. Critical evaluation of oncology clinical practice guidelines. Journal of Clinical Oncology. 2013; 31(20):2563-8.

Detsky AS. Sources of bias for authors of clinical practice guidelines. Canadian Medical Association Journal. 2006; 175(9):1033-.

Published
2018-10-18
Info
Issue
Section
Reviews
Keywords:
Appraising, quality, clinical guidelines, peripheral neuropathy.
Statistics
  • Abstract views: 823

  • PDF: 586
  • HTML: 53
How to Cite
Salarvand, S., Hemati, S., Adibi, P., & Taleghani, F. (2018). The quality of guidelines in non-pharmacological prevention and management of chemotherapy-induced neuropathy: A review. Oncology Reviews, 12(2). https://doi.org/10.4081/oncol.2018.359